MedPath
FDA Approval

Renvela

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Genzyme Corporation
DUNS: 025322157
Effective Date
September 25, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Sevelamer(2400 mg in 1 1)

Manufacturing Establishments6

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Eurofins Biopharma Product Testing Ireland Limited

Genzyme Corporation

238239933

Reed-Lane, Inc.

Genzyme Corporation

001819879

EUROAPI UK LIMITED

Genzyme Corporation

229522842

Rovi Pharma Industrial Services SA

Genzyme Corporation

462117953

Sanofi Winthrop Industrie

Genzyme Corporation

763683216

Genzyme Ireland Limited

Genzyme Corporation

985127419

Products4

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Renvela

Product Details

NDC Product Code
58468-0131
Application Number
NDA022318
Marketing Category
NDA (C73594)
Route of Administration
ORAL
Effective Date
September 25, 2023
PROPYLENE GLYCOL ALGINATEInactive
Code: 26CD3J2R0CClass: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRTClass: IACT
SevelamerActive
Code: 9YCX42I8IUClass: ACTIBQuantity: 2400 mg in 1 1
SUCRALOSEInactive
Code: 96K6UQ3ZD4Class: IACT

Renvela

Product Details

NDC Product Code
58468-0132
Application Number
NDA022318
Marketing Category
NDA (C73594)
Route of Administration
ORAL
Effective Date
September 25, 2023
SUCRALOSEInactive
Code: 96K6UQ3ZD4Class: IACT
PROPYLENE GLYCOL ALGINATEInactive
Code: 26CD3J2R0CClass: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRTClass: IACT
SevelamerActive
Code: 9YCX42I8IUClass: ACTIBQuantity: 800 mg in 1 1

Renvela

Product Details

NDC Product Code
58468-0130
Application Number
NDA022127
Marketing Category
NDA (C73594)
Route of Administration
ORAL
Effective Date
September 25, 2023
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WOClass: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACT
DIACETYLATED MONOGLYCERIDESInactive
Code: 5Z17386USFClass: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61UClass: IACT
SevelamerActive
Code: 9YCX42I8IUClass: ACTIBQuantity: 800 mg in 1 1
ZINC STEARATEInactive
Code: H92E6QA4FVClass: IACT
FERROSOFERRIC OXIDEInactive
Code: XM0M87F357Class: IACT

Renvela

Product Details

NDC Product Code
58468-0133
Application Number
NDA022127
Marketing Category
NDA (C73594)
Route of Administration
ORAL
Effective Date
September 25, 2023
FERROSOFERRIC OXIDEInactive
Code: XM0M87F357Class: IACT
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WOClass: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61UClass: IACT
DIACETYLATED MONOGLYCERIDESInactive
Code: 5Z17386USFClass: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACT
ZINC STEARATEInactive
Code: H92E6QA4FVClass: IACT
SevelamerActive
Code: 9YCX42I8IUClass: ACTIBQuantity: 800 mg in 1 1
© Copyright 2025. All Rights Reserved by MedPath